Structures by: Krishnaswamy S.
Total: 47
? 4-(2-Chlorophenyl)-1-(3-nitrophenyl)-1H-1,2,3-triazole
C14H9ClN4O2
CrystEngComm (2013) 15, 26 5283
a=12.448(4)Å b=6.999(2)Å c=15.083(4)Å
α=90.00° β=95.273(6)° γ=90.00°
? 4-(4-Chlorophenyl)-1-(2-nitrophenyl)-1H-1,2,3-triazole
C14H9ClN4O2
CrystEngComm (2013) 15, 26 5283
a=10.8467(15)Å b=14.129(2)Å c=26.790(4)Å
α=90.00° β=90.00° γ=90.00°
? 4-(3-Chlorophenyl)-1-(3-nitrophenyl)-1H-1,2,3-triazole
C14H9ClN4O2
CrystEngComm (2013) 15, 26 5283
a=7.080(2)Å b=8.369(2)Å c=13.026(4)Å
α=102.628(4)° β=94.538(5)° γ=114.741(4)°
? 4-(3-Chlorophenyl)-1-(4-nitrophenyl)-1H-1,2,3-triazole
C14H9ClN4O2
CrystEngComm (2013) 15, 26 5283
a=8.550(5)Å b=5.256(3)Å c=29.749(18)Å
α=90.00° β=96.543(10)° γ=90.00°
? 4-(4-Chlorophenyl)-1-(2-nitrophenyl)-1H-1,2,3-triazole
C14H9ClN4O2
CrystEngComm (2013) 15, 26 5283
a=7.013(4)Å b=7.312(4)Å c=13.309(7)Å
α=94.793(8)° β=96.114(8)° γ=107.261(8)°
? 4-(4-Chlorophenyl)-1-(4-nitrophenyl)-1H-1,2,3-triazole
C14H9ClN4O2
CrystEngComm (2013) 15, 26 5283
a=7.954(7)Å b=13.263(11)Å c=12.684(11)Å
α=90.00° β=94.559(14)° γ=90.00°
C14H9IN4O2
C14H9IN4O2
CrystEngComm (2013) 15, 26 5283
a=9.4462(15)Å b=7.2925(11)Å c=20.875(3)Å
α=90.00° β=96.379(2)° γ=90.00°
C14H9IN4O2
C14H9IN4O2
CrystEngComm (2013) 15, 26 5283
a=5.431(2)Å b=21.767(9)Å c=12.162(5)Å
α=90.00° β=101.372(7)° γ=90.00°
C14H9IN4O2
C14H9IN4O2
CrystEngComm (2013) 15, 26 5283
a=8.9450(14)Å b=15.147(2)Å c=10.2164(17)Å
α=90.00° β=92.321(3)° γ=90.00°
C14H9IN4O2
C14H9IN4O2
CrystEngComm (2013) 15, 26 5283
a=7.587(4)Å b=8.310(4)Å c=12.755(6)Å
α=95.053(7)° β=100.946(7)° γ=116.761(7)°
C14H9IN4O2
C14H9IN4O2
CrystEngComm (2013) 15, 26 5283
a=7.1884(8)Å b=11.9850(13)Å c=16.2685(17)Å
α=90.00° β=96.660(2)° γ=90.00°
C14H9IN4O2
C14H9IN4O2
CrystEngComm (2013) 15, 26 5283
a=7.8521(11)Å b=7.0890(10)Å c=24.500(3)Å
α=90.00° β=90.151(2)° γ=90.00°
C14H9IN4O2
C14H9IN4O2
CrystEngComm (2013) 15, 26 5283
a=27.638(6)Å b=5.5912(13)Å c=17.974(4)Å
α=90.00° β=96.932(6)° γ=90.00°
? 4-(2-Chlorophenyl)-1-(2-nitrophenyl)-1H-1,2,3-triazole
C14H9Cl1N4O2
CrystEngComm (2013) 15, 26 5283
a=12.340(3)Å b=7.8967(15)Å c=14.187(3)Å
α=90.00° β=100.414(3)° γ=90.00°
? 4-(3-Chlorophenyl)-1-(2-nitrophenyl)-1H-1,2,3-triazole
C14H9ClN4O2
CrystEngComm (2013) 15, 26 5283
a=7.705(18)Å b=7.191(18)Å c=12.34(3)Å
α=90.00° β=92.39(7)° γ=90.00°
? 4-(4-Chlorophenyl)-1-(3-nitrophenyl)-1H-1,2,3-triazole
C14H9ClN4O2
CrystEngComm (2013) 15, 26 5283
a=7.587(8)Å b=13.601(14)Å c=13.338(13)Å
α=90.00° β=91.266(17)° γ=90.00°
C14H9IN4O2
C14H9IN4O2
CrystEngComm (2013) 15, 26 5283
a=5.4744(14)Å b=11.366(3)Å c=11.235(3)Å
α=90.00° β=93.816(4)° γ=90.00°
C14H9IN4O2
C14H9IN4O2
CrystEngComm (2013) 15, 26 5283
a=8.566(4)Å b=8.694(4)Å c=10.011(5)Å
α=85.508(7)° β=71.441(7)° γ=72.559(7)°
4-O-benzyl-myo-inositol-1,3,5-orthoformate
C14H16O6
CrystEngComm (2012) 14, 23 8010
a=10.4043(17)Å b=13.720(2)Å c=10.3515(17)Å
α=90.00° β=118.031(3)° γ=90.00°
4-O-benzyl-myo-inositol-1,3,5-orthoformate
C14H16O6
CrystEngComm (2012) 14, 23 8010
a=10.460(5)Å b=11.536(5)Å c=42.364(19)Å
α=90.00° β=90.00° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate dimethyl sulphoxide solvate
C21H16Cl2O8,C2H6OS
CrystEngComm (2010) 12, 12 4184
a=12.9731(13)Å b=10.2342(11)Å c=18.0469(19)Å
α=90.00° β=102.585(2)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate dioxane solvate
C21H16Cl2O8,C4H8O2
CrystEngComm (2010) 12, 12 4184
a=13.047(3)Å b=10.141(3)Å c=18.678(5)Å
α=90.00° β=103.518(4)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate 1,2- dichloroethane solvate
C21H16Cl2O8,C2H4Cl2
CrystEngComm (2010) 12, 12 4184
a=12.093(2)Å b=9.9108(17)Å c=20.260(3)Å
α=90.00° β=92.433(3)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate acetonitrile solvate
C21H16Cl2O8,C2H3N
CrystEngComm (2010) 12, 12 4184
a=12.074(10)Å b=9.861(8)Å c=20.003(16)Å
α=90.00° β=94.894(13)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate benzene solvate
C21H16Cl2O8,0.5(C6H6)2
CrystEngComm (2010) 12, 12 4184
a=32.22(3)Å b=9.584(8)Å c=21.386(19)Å
α=90.00° β=129.72(3)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate dichloromethane solvate
C21H16Cl2O8,0.06(CH2Cl2)
CrystEngComm (2010) 12, 12 4184
a=12.962(2)Å b=10.1406(17)Å c=18.391(3)Å
α=90.00° β=102.627(3)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate chloroform solvate
C21H16Br2O8,CHCl3
CrystEngComm (2010) 12, 12 4184
a=12.8141(17)Å b=10.2601(14)Å c=18.756(3)Å
α=90.00° β=102.832(2)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate acetone solvate
C21H16Br2O8,C3H6O
CrystEngComm (2010) 12, 12 4184
a=12.8133(15)Å b=10.2045(12)Å c=18.814(2)Å
α=90.00° β=103.599(2)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate dichloromethane solvate
C21H16Br2O8,CH2Cl2
CrystEngComm (2010) 12, 12 4184
a=12.8524(11)Å b=10.2018(8)Å c=18.5250(15)Å
α=90.00° β=102.8700(10)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate nitromethane solvate
C21H16Br2O8,CH3NO2
CrystEngComm (2010) 12, 12 4184
a=12.1747(15)Å b=10.1533(12)Å c=19.261(2)Å
α=90.00° β=103.231(2)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate tetrahydrofuran solvate
C21H16Br2O8,C4H8O
CrystEngComm (2010) 12, 12 4184
a=13.181(4)Å b=10.046(3)Å c=18.813(5)Å
α=90.00° β=102.436(4)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate dioxane solvate
C21H16Br2O8,C4H8O2
CrystEngComm (2010) 12, 12 4184
a=13.1856(16)Å b=10.2483(13)Å c=18.966(2)Å
α=90.00° β=104.704(2)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate dimethyl sulphoxide solvate
C21H16Br2O8,C2H6OS
CrystEngComm (2010) 12, 12 4184
a=13.0322(15)Å b=10.2499(11)Å c=18.415(2)Å
α=90.00° β=103.579(2)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate 1,2- dichloroethane solvate
C21H16Br2O8,C2H4Cl2
CrystEngComm (2010) 12, 12 4184
a=12.1687(8)Å b=10.0099(7)Å c=20.3518(14)Å
α=90.00° β=92.6770(10)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate chloroform solvate
C21H16Cl2O8,CHCl3
CrystEngComm (2010) 12, 12 4184
a=12.9486(9)Å b=10.2705(7)Å c=18.0529(12)Å
α=90.00° β=101.3980(10)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate acetone solvate
C21H16Cl2O8,C3H6O
CrystEngComm (2010) 12, 12 4184
a=12.751(2)Å b=10.2210(18)Å c=18.520(3)Å
α=90.00° β=103.209(3)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate dichloromethane solvate
C21H16Cl2O8,CH2Cl2
CrystEngComm (2010) 12, 12 4184
a=12.8921(11)Å b=10.1356(9)Å c=18.0788(16)Å
α=90.00° β=101.5840(10)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate nitromethane solvate
C21H16Cl2O8,CH3NO2
CrystEngComm (2010) 12, 12 4184
a=12.6835(7)Å b=10.0712(5)Å c=18.2980(10)Å
α=90.00° β=103.1000(10)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate tetrahydrofuran solvate
C21H16Cl2O8,C4H8O
CrystEngComm (2010) 12, 12 4184
a=12.908(3)Å b=10.135(2)Å c=18.299(4)Å
α=90.00° β=101.682(4)° γ=90.00°
6-<i>O</i>-acryloyl-2-<i>O</i>-benzoyl-<i>myo</i>-inositol 1,3,5-orthoformate
C17H16O8
Acta Crystallographica Section C (2009) 65, 2 o54-o57
a=8.8808(6)Å b=9.5502(6)Å c=9.7100(6)Å
α=102.2660(10)° β=101.7330(10)° γ=94.3340(10)°
6-<i>O</i>-acryloyl-2-<i>O</i>-benzoyl-<i>myo</i>-inositol 1,3,5-orthoformate
C17H16O8
Acta Crystallographica Section C (2009) 65, 2 o54-o57
a=13.813(4)Å b=19.279(5)Å c=5.9801(15)Å
α=90.00° β=96.665(4)° γ=90.00°
Racemic epi-inosose
C6H10O6
Acta Crystallographica Section C (2011) 67, 11 o435-o438
a=11.1825(18)Å b=6.9752(12)Å c=8.7930(15)Å
α=90.00° β=90.00° γ=90.00°
2-O-tosyl-6-O-benzoyl-myo-inositol 1,3,5-orthoformate
C21H20O9S
The Journal of organic chemistry (2018) 83, 7 3952-3959
a=11.626(5)Å b=12.534(5)Å c=13.719(6)Å
α=90° β=95.573(7)° γ=90°
2,6-Di-O-(4-iodobenzoyl)-myo-inositol 1,3,5-orthoformate
C21H16I2O8
The Journal of organic chemistry (2018) 83, 7 3952-3959
a=6.8984(12)Å b=36.230(7)Å c=8.3985(15)Å
α=90° β=96.013(3)° γ=90°
2,6-di-O-(4-toluoyl) myo-inositol 1,3,5-orthoformate
C23H22O8
The Journal of organic chemistry (2018) 83, 7 3952-3959
a=6.8474(15)Å b=11.558(3)Å c=13.858(3)Å
α=108.274(4)° β=98.891(4)° γ=90.870(4)°
2-O-(4-toluoyl)myo-inositol 1,3,5-orthoformate
C15H16O7
The Journal of organic chemistry (2018) 83, 7 3952-3959
a=27.213(4)Å b=7.7759(12)Å c=6.5598(10)Å
α=90° β=90° γ=90°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate p- xylene solvate
C21H16Cl2O8,0.5(C8H10)
CrystEngComm (2010) 12, 12 4184
a=11.6917(18)Å b=9.6018(15)Å c=21.103(3)Å
α=90.00° β=94.329(3)° γ=90.00°